EFMC-ASMC'17

EFMC International Symposium on Advances in Synthetic and Medicinal Chemistry

 Vienna, Austria    August 27-31, 2017

Confirmed Invited Speakers

T15 - Ring Construction by Pd-catalyzed C(sp3)-H Activation

 Olivier BAUDOIN
Olivier BAUDOIN
UNIVERSITY OF BASEL, Basel, Switzerland
Read more

T10 - Azidoperfluoroalkanes - Neglected, Stable and Useful Fluorinated Synthons

  Petr BEIER
Petr BEIER
ACADEMY OF SCIENCES OF THE CZECH REPUBLIC, Prague, Czech Republic
Read more

T02 - Next-Generation Small Molecule Therapeutics

 James E BRADNER
James E BRADNER
NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, Cambridge, MA, United States
Read more

T03 - Drugging the Undruggable

 Mark BUNNAGE
Mark BUNNAGE
VERTEX PHARMACEUTICALS, Boston, United States
Read more

T07 - Beta-secretase Inhibitors as a Therapy for Alzheimer’s Disease – Where Are We Now?

 Roland BÜRLI
Roland BÜRLI
ASTRAZENECA, Cambridge, United Kingdom
Read more

T25 - More Options, More Complexity: Medicinal Chemistry Mastering Mixed Modalities

 Werngard CZECHTIZKY
Werngard CZECHTIZKY
SANOFI, Mölndal, Sweden
Read more

T22 - Collaborative Academic/Industrial Research Under the Umbrella of the NSF Center for Selective C-H Functionalization

 Huw DAVIES
Huw DAVIES
EMORY UNIVERSITY, Atlanta, United States
Read more

T24 - Synthetic, Mechanistic and Computational Studies on Reactions of Interest

 Scott E. DENMARK
Scott E. DENMARK
UNIVERSITY OF ILLINOIS, Urbana, United States
Read more

T13 - Isosteric-Switch Strategies: New Concepts and Recent Advances

 Thomas C. FESSARD
Thomas C. FESSARD
SPIROCHEM AG, Basel, Switzerland
Read more

T26 - DNA Repair Inhibition in Cancer Therapy: DNA-PK Inhibitor M3814

 Thomas FUCHSS
Thomas FUCHSS
MERCK KGAA, Darmstadt, Germany
Read more

T18 - Exploiting Physical Organic Principles in Reaction Design

 Ryan GILMOUR
Ryan GILMOUR
UNIVERSITY OF MÜNSTER, Münster, Germany
Read more

T27 - Late Stage 18F-Fluorination for PET Imaging

 Véronique GOUVERNEUR
Véronique GOUVERNEUR
UNIVERSITY OF OXFORD, Oxford, United Kingdom
Read more

T19 - Automation, Integration and Miniaturization In Drug Discovery Synthesis

 Guido KOCH
Guido KOCH
NOVARTIS PHARMA AG, Schlieren, Switzerland
Read more

T12 - Organic Synthesis with Rearrangements - Adventures in Total Synthesis

 Nuno MAULIDE
Nuno MAULIDE
UNIVERSITY OF VIENNA, Vienna, Austria
Read more

T11 - HIV-1 Maturation Inhibitors

 Nicholas MEANWELL
Nicholas MEANWELL
BRISTOL-MYERS SQUIBB, Wallingford, United States
Read more

T06 - Single Electron Processes to Enable Organic Synthesis

 Gary A. MOLANDER
Gary A. MOLANDER
UNIVERSITY OF PENNSYLVANIA, Philadelphia, United States
Read more

T08 - Idea2Data: Augmenting Drug Discovery Efforts through Synthetic Reaction Data Mining and Automation

 Christos A. NICOLAOU
Christos A. NICOLAOU
ELI LILLY, Indianapolis, United States
Read more

T21 - With Asymmetric Hydrogenation towards a Scalable, Stereoselective Synthesis of Bitopertin

 Michelangelo SCALONE
Michelangelo SCALONE
F. HOFFMANN-LA ROCHE AG, Basel, Switzerland
Read more

T14 - Iron(III)-Catalyzed Carbonyl-Olefin Metathesis

 Corinna SCHINDLER
Corinna SCHINDLER
UNIVERSITY OF MICHIGAN, Ann Arbor, United States
Read more

T17 - Adventures in Catalysis: from Mechanisms to Applications

 Franziska SCHOENEBECK
Franziska SCHOENEBECK
RWTH AACHEN, Aachen, Germany
Read more

T23 - Strategies towards Increasing the 3-Dimensionality of the Medicinal Chemistry Design Space

 Antonia F. STEPAN
Antonia F. STEPAN
PFIZER, Basel, Switzerland
Read more

T09 - A RaPID Way to Discover Pseudo-natural Peptides

 Hiroaki SUGA
Hiroaki SUGA
UNIVERSITY OF TOKYO, Tokyo, Japan
Read more

Opening Lecture
T01 - Photochemistry and Photopharmacology in Medicine

 Dirk TRAUNER
Dirk TRAUNER
NEW YORK UNIVERSITY, New York, United States
Read more

T20 - Design and Evolution of New Biocatalysts for Organic Synthesis

 Nicholas John TURNER
Nicholas John TURNER
UNIVERSITY OF MANCHESTER, Manchester, United Kingdom
Read more

T16 - Merck Drug Discovery through Enabling Capabilities

 Petr VACHAL
Petr VACHAL
MERCK & CO. INC (MSD), Kenilworth, United States
Read more

T04 - Bioinspired Asymmetric Catalysis

 Helma WENNEMERS
Helma WENNEMERS
ETH ZURICH, Zürich, Switzerland
Read more

T05 - Strategies to Facilitate the Discovery of Novel CNS PET Ligands

 Lei ZHANG
Lei ZHANG
PFIZER, Cambridge, United States
Read more

Oral Communications

OC09 - Development of Synthesis Strategies to DNA-Encoded Compound Libraries - of a Chemoresistant Sequence, and Micellar Nanoreactors

 Andreas BRUNSCHWEIGER
Andreas BRUNSCHWEIGER
TU DORTMUND, Dortmund, Germany
Read more

OC06 - Expanding Screening Decks by Innovative MCR Scaffolds

 Alexander DÖMLING
Alexander DÖMLING
UNIVERSITY OF GRONINGEN, Groningen, The Netherlands
Read more

OC02 - Chemically Induced Degradation of the Oncogenic Transcription Factor BCL6

 Peter ETTMAYER
Peter ETTMAYER
BOEHRINGER-INGELHEIM, Vienna, Austria
Read more

EFMC Prize for a Young Medicinal Chemist in Academia
OC10 - Nature-Derived Peptides as Pharmacological Tools to Design Novel Therapeutics

 Christian W. GRUBER
Christian W. GRUBER
MEDICAL UNIVERSITY OF VIENNA, Vienna, Austria
Read more

EFMC Prize for a Young Medicinal Chemist in Industry:
OC11 - The Development of non-BET Bromodomain Chemical Probes

 Phil HUMPHREYS
Phil HUMPHREYS
GLAXOSMITHKLINE, Stevenage, United Kingdom
Read more

PRIZE winner EFMC-YMCS 2016
OC04 - Development of Highly Selective and Reversible Diacylglycerol Lipase Inhibitors

 Freek JANSSEN
Freek JANSSEN
LEIDEN UNIVERSITY, Nijmegen, The Netherlands
Read more

OC01 - Stereoselective Peptide Modifications – Efficient Tools for Natural Product and Drug Synthesis

 Uli KAZMAIER
Uli KAZMAIER
SAARLAND UNIVERSITY, Saarbrücken, Germany
Read more

OC03 - Mimicking Nature Complexity with 3D-Fragments Assembly

 Hugues LEMOINE
Hugues LEMOINE
EDELRIS, LYON, France
Read more

OC12 - Discovery of UCB0942, the First Rationally Designed Antiepileptic Drug with a Dual Mechanism of Action for the Treatment of Drug-Resistant Epilepsy

 Laurent PROVINS
Laurent PROVINS
UCB, Braine-l'Alleud, Belgium
Read more

OC07 - The Discovery of Soluble Guanylate Cyclase Stimulators for the Treatment of Pulmonary Arterial Hypertension

 Subharekha RAGHAVAN
Subharekha RAGHAVAN
MERCK & CO. INC (MSD), Kenilworth, New Jersey, United States
Read more

OC05 - Discovery of RG7314, a Vasopressin 1a Receptor Antagonist for the Treatment of Social Communication Deficits in Autism Spectrum Disorders

 Patrick SCHNIDER
Patrick SCHNIDER
F. HOFFMANN-LA ROCHE, Basel, Switzerland
Read more

OC08 - Exploring New Methods for Facile Synthesis of Some Biologically Interesting Molecules

 Ming-Hua XU
Ming-Hua XU
SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES, Shanghai, China
Read more